Zhu Yunpeng, Chen Anqing, Wang Zhe, Liu Jun, Cai Junfeng, Zhou Mi, Zhao Qiang
Department of Cardiac Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):559-564. doi: 10.1093/icvts/ivx174.
Long-term effectiveness of coronary artery bypass grafting using radial artery (RA) or great saphenous vein (SVG) grafts as a second conduit was compared.
Patients received simple elective off-pump coronary artery bypass involving both the left internal thoracic artery (LITA) and the left anterior descending artery between January 1999 and December 2005 at Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China. RA graft patients (n = 147 LITA + RA and n = 61 LITA + RA + SVG) were matched with SVG graft patients (n = 208 LITA + SVG). Mean follow-up was 86.5 months.
Baseline characteristics were comparable before and after surgery. Intraoperative hospital mortality was not significantly different. In all, 378 (90.9%) patients completed postoperative follow-up (197 in the RA and 181 in SVG). Overall survival was significantly better in the RA group (Log-rank, P = 0.017) with 88% 10-year survival in the RA group and 81% in the SVG group. All-cause mortality was significantly lower in the RA group (hazard ratio 0.42, 95% confidence interval 0.20-0.88, P = 0.020). Major adverse cardiovascular event-free survival was significantly better in the RA group than in the SVG group (Log-rank, P = 0.019). No significant difference in the length of postoperative angina relief was found.
Using the RA as the secondary graft for coronary artery bypass grafting improved long-term postoperative survival and reduced the incidence of postoperative major adverse cardiovascular events.
比较使用桡动脉(RA)或大隐静脉(SVG)作为第二根移植血管进行冠状动脉旁路移植术的长期疗效。
1999年1月至2005年12月期间,在中国上海交通大学医学院附属瑞金医院,患者接受了单纯择期非体外循环冠状动脉旁路移植术,涉及左内乳动脉(LITA)和左前降支动脉。RA移植患者(n = 147例LITA + RA和n = 61例LITA + RA + SVG)与SVG移植患者(n = 208例LITA + SVG)进行匹配。平均随访时间为86.5个月。
手术前后的基线特征具有可比性。术中住院死亡率无显著差异。共有378例(90.9%)患者完成了术后随访(RA组197例,SVG组181例)。RA组的总体生存率显著更高(对数秩检验,P = 0.017),RA组10年生存率为88%,SVG组为81%。RA组的全因死亡率显著更低(风险比0.42,95%置信区间0.20 - 0.88,P = 0.020)。RA组无重大不良心血管事件生存率显著优于SVG组(对数秩检验,P = 0.019)。术后心绞痛缓解时间无显著差异。
使用RA作为冠状动脉旁路移植术的第二根移植血管可提高术后长期生存率,并降低术后重大不良心血管事件的发生率。